Talkspace, Inc.
NASDAQ:TALKMedical - Care Facilities
+$0.01 today
- Market cap
- $879.44M
- Beta
- 1.07
- P/E (TTM)
- 749.9
- EPS (TTM)
- $0.01
Volume 2.41M
Average 2.55M
TALK Total Non-current Assets
All assets not expected to be converted to cash within one year.
Talkspace, Inc.NASDAQ: TALK
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets rises 153.7% from a year ago
Total non-current assets stood at $25.69M at the end of Q1 FY2026, up 153.7% from a year earlier and up 7.9% from the prior quarter. Over 3 fiscal years it compounded at +86.0% a year.
Context
- Total non-current assets amounted to 18.9% of total assets at the end of Q1 FY2026, up 11.3 pp from a year earlier.
- Total non-current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps rising in the next quarterly balance sheet after a +153.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 23.8M USD
- Year-over-year change
- +180.2%
- 4-year CAGR
- +23.4%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.8M | +180.2% |
| FY2024 | 2024-12-31 | 8.5M | +250.9% |
| FY2023 | 2023-12-31 | 2.42M | -34.5% |
| FY2022 | 2022-12-31 | 3.7M | -64.0% |
| FY2021 | 2021-12-31 | 10.28M | — |
Total Non-current Assets vs competitors
How TALK compares with its peers on the latest reported figures
- TALK's Mar 2026 total non-current assets of $25.69M is the 8th highest of the 11 companies compared; the peer median is $219.12M.
- Its year-over-year change of +153.7% is the 4th highest of 10, against a peer median of -4.0%.
- Total non-current assets amounts to 18.9% of total assets for TALK, versus a peer median of 58.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $9.41B | -10.3% | -4.9% | 71.4% | |
| Mar 2026 | $2.48B | +221.8% | +7.5% | 94.4% | |
| Mar 2026 | $725.1M | -4.0% | -14.8% | 69.1% | |
| Mar 2026 | $344.78M | -4.4% | +5.8% | 63.0% | |
| Mar 2026 | $270.58M | +820.1% | +146.0% | 53.6% | |
| Mar 2026 | $167.67M | -10.8% | -2.3% | 87.3% | |
| Mar 2026 | $38.54M | +558.1% | +99.4% | 41.3% | |
| Mar 2026 | $25.69M | +153.7% | +86.0% | 18.9% | |
| Mar 2026 | $20.87M | +52.7% | +49.5% | 3.9% | |
| Dec 2025 | $15.23M | — | — | 4.5% | |
NNNNAnbio Biotechnology Class A Ordinary Shares | Dec 2025 | $0 | -100.0% | — | 0.0% |
| Peer median (excluding TALK) | $219.12M | -4.0% | +6.6% | 58.3% | |
Competitors are the stored peer set for TALK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 198.26M | 138.55M | 123.91M | 76.69M | 37.35M |
| Short-term Investments | 0 | 0 | 0 | 41.12M | 55.23M |
| Net Receivables | 5.51M | 9.64M | 10.17M | 9.64M | 16.06M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 9.56M | 4.37M | 5.72M | 2.73M | 2.42M |
| Total Current Assets | 213.33M | 152.56M | 139.8M | 130.18M | 111.06M |
| Property, Plant & Equipment (Net) | 624K | 677K | 314K | 6.26M | 15.79M |
| Goodwill | 6.13M | 0 | 0 | 0 | 3.32M |
| Intangible Assets | 3.44M | 2.53M | 1.79M | 1.34M | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 82K | 491K | 321K | 897K | 4.69M |
| Total Non-current Assets | 10.28M | 3.7M | 2.42M | 8.5M | 23.8M |
| Total Assets | 223.61M | 156.25M | 142.22M | 138.68M | 134.86M |
| Account Payables | 7.43M | 6.46M | 6.11M | 7.71M | 8.5M |
| Short-term Debt | 0 | 200K | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 7.19M | 4.36M | 3.07M | 3.28M | 2.22M |
| Other Current Liabilities | 6.57M | 11.01M | 5.2M | 2.39M | 6.67M |
| Total Current Liabilities | 27.18M | 27.32M | 21.65M | 19.02M | 17.4M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 4.16M | 1.1M | 1.93M | 2.26M | 452K |
| Total Non-current Liabilities | 4.16M | 1.4M | 1.93M | 2.26M | 452K |
| Total Liabilities | 31.33M | 28.72M | 23.58M | 21.28M | 17.85M |
| Common Stock | 15K | 16K | 16K | 17K | 17K |
| Retained Earnings | (171.53M) | (251.2M) | (270.38M) | (269.24M) | (261.44M) |
| Accumulated OCI | (223.61M) | 0 | 0 | 2K | 57K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 192.27M | 127.54M | 118.65M | 117.4M | 117.02M |
| Total Debt | 0 | 500K | 0 | 0 | 0 |
| Net Debt | (198.26M) | (138.05M) | (123.91M) | (76.69M) | (37.35M) |
Talkspace, Inc.
NASDAQ:TALK
Intrinsic Alpha fair value
Locked
Current Price
$5.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.